Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Other companies in Altimmune’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Sangamo Therapeutics (NASDAQ:SGMO), Opthea (NASDAQ:OPT) and Olema Pharmaceuticals (NASDAQ:OLMA).
Altimmune has a consensus price target of $22.50.
The stock price for Altimmune (NASDAQ: ALT) is $7.55 last updated December 24, 2024 at 4:54 PM EST.
There are no upcoming dividends for Altimmune.
Altimmune’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.